LipidDrive | LipidDrive - Lipidomics cloud computing platform and app

Summary
LipidDrive is a breakthrough cloud computing platform and mobile app that allows researchers in the growing field of lipidomics to process, store and share analytical data in a standardized format.
Lipidomics is the study of lipid molecules in cells, tissues and biofluids. Due to its low cost, high accuracy and deep insights into cellular function, it has the potential to revolutionize medical science. However it is blocked by a lack of data standardization, processing capacity and collaboration.
There are no common protocols for lipidomics data output. 70% of lipidomics data is incomparible, wasting €14 million in research costs annually. Tests require large computer processing power, which most researchers do not possess. There are few online resources for data collaboration.
Addressing these challenges, LipidDrive is a cloud-based platform for high-quality lipidomics data analysis. Users upload mass spectrometry data sets, which are processed by algorithms to ensure quality control, and are output according to new data standards. LipidDrive’s cloud computing service processes high-throughput data in any format, replacing desktop-based software with limited capacity. It also provides an online resource of latest research, lipid and biomarker libraries, communication tools and APIs for third-party data utilization.
LipidDrive is an unrivaled ICT service developed by Dr Kim Ekroos, a leading lipidomics expert. It will target researchers in universities, pharmaceutical and nutritional industries, and hospitals and clinics through direct sales and partnerships with hardware vendors. Demand and willingness to pay have been confirmed by interest from several large pharmaceutical companies.
Lipidomics is expected to follow the growth path of proteomics, which is worth €20 billion annually. LipidDrive will become the most valuable online resource for this fast-emerging industry. The proposed feasibility study will test the technology and prepare for commercialization.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/781726
Start date: 01-09-2017
End date: 28-02-2018
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

LipidDrive is a breakthrough cloud computing platform and mobile app that allows researchers in the growing field of lipidomics to process, store and share analytical data in a standardized format.
Lipidomics is the study of lipid molecules in cells, tissues and biofluids. Due to its low cost, high accuracy and deep insights into cellular function, it has the potential to revolutionize medical science. However it is blocked by a lack of data standardization, processing capacity and collaboration.
There are no common protocols for lipidomics data output. 70% of lipidomics data is incomparible, wasting €14 million in research costs annually. Tests require large computer processing power, which most researchers do not possess. There are few online resources for data collaboration.
Addressing these challenges, LipidDrive is a cloud-based platform for high-quality lipidomics data analysis. Users upload mass spectrometry data sets, which are processed by algorithms to ensure quality control, and are output according to new data standards. LipidDrive’s cloud computing service processes high-throughput data in any format, replacing desktop-based software with limited capacity. It also provides an online resource of latest research, lipid and biomarker libraries, communication tools and APIs for third-party data utilization.
LipidDrive is an unrivaled ICT service developed by Dr Kim Ekroos, a leading lipidomics expert. It will target researchers in universities, pharmaceutical and nutritional industries, and hospitals and clinics through direct sales and partnerships with hardware vendors. Demand and willingness to pay have been confirmed by interest from several large pharmaceutical companies.
Lipidomics is expected to follow the growth path of proteomics, which is worth €20 billion annually. LipidDrive will become the most valuable online resource for this fast-emerging industry. The proposed feasibility study will test the technology and prepare for commercialization.

Status

CLOSED

Call topic

SMEInst-06-2016-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well